| Literature DB >> 7761548 |
F Brambilla1, L Bellodi, G Perna, A Bertani, A Panerai, P Sacerdote.
Abstract
Plasma interleukin-1 beta (IL-1 beta) concentrations were measured in 10 outpatients with panic disorder before and on days 30 and 32 of treatment with alprazolam (2-2.5 mg/day). IL-1 beta concentrations were found to be significantly higher in patients than in control subjects both before and during therapy. Thus, IL-1 beta levels may be a marker of panic disorder that is not related to the current level of symptomatology.Entities:
Mesh：
Substances：
Year: 1994 PMID： 7761548 DOI： 10.1016/0165-1781(94)90002-7
Source DB: PubMed Journal: Psychiatry Res ISSN： 0165-1781 Impact factor: 3.222